Stay updated on Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial
Sign up to get notified when there's something new on the Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial page.

Latest updates to the Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This appears to be a backend version update with no visible changes to study details.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page now displays Revision: v3.4.3, replacing Revision: v3.4.2.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision: v3.4.2 replaces v3.4.1. No user-facing content or functional changes are evident from the available context.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision: v3.4.1 was added and v3.4.0 removed, indicating a minor backend version update with no visible changes to the page content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check74 days agoChange DetectedShow glossary and Hide glossary UI options were added, and new metadata labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0) were introduced. The corresponding older labels (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4) were removed or updated.SummaryDifference0.3%

- Check81 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no study content or functionality changes were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial page.